Reaction
Impetigo reporting signals
As of the last recalculation, Impetigo appears in 1,463 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is TERBINAFINE HYDROCHLORIDE (PRR 35.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Terbinafine Hydrochloride | 22 | 35.8 | 35.8 |
| Mupirocin | 21 | 22.5 | 22.5 |
| Mupirocin Calcium | 21 | 22.0 | 22.1 |
| Ketoconazole Foam | 19 | 18.5 | 18.5 |
| Ketoconazole Cream, 2% | 19 | 18.4 | 18.5 |
| Ketoconazole | 22 | 18.3 | 18.4 |
| Canakinumab | 11 | 14.6 | 14.6 |
| Panitumumab | 12 | 11.0 | 11.0 |
| Crisaborole | 5 | 7.4 | 7.4 |
| Baricitinib | 5 | 7.4 | 7.4 |
| Ixekizumab | 19 | 7.4 | 7.4 |
| Isotretinoin | 25 | 7.3 | 7.3 |
| Levocetirizine Dihydrochloride | 11 | 6.6 | 6.6 |
| Gefitinib | 4 | 6.3 | 6.3 |
| Secukinumab | 65 | 6.0 | 6.0 |
| Bimekizumab | 8 | 5.4 | 5.4 |
| Trametinib | 8 | 4.7 | 4.7 |
| Lapatinib | 5 | 4.6 | 4.6 |
| Sarilumab | 7 | 3.8 | 3.8 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 3.8 | 3.8 |
| Buprenorphine | 19 | 2.9 | 2.9 |
| Dupilumab | 94 | 2.9 | 2.9 |
| Palivizumab | 3 | 2.8 | 2.8 |
| Pegfilgrastim | 16 | 2.3 | 2.3 |
| Salicylic Acid | 3 | 0.8 | 0.8 |
| Adapalene | 8 | 0.6 | 0.6 |